The importance of molecular phenotype in predicting overall survival in patients with relapsed or primary refractory DLBCL treated with second-line chemotherapy and ASCT Meeting Abstract
| Authors: | Moskowitz, C. H.; Kewalramani, T.; Hamlin, P.; Nimer, S. D.; Zelenetz, A. D.; Teruya-Feldstein, J. |
| Abstract Title: | The importance of molecular phenotype in predicting overall survival in patients with relapsed or primary refractory DLBCL treated with second-line chemotherapy and ASCT |
| Meeting Title: | 46th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 104 |
| Issue: | 11 Pt. 1 |
| Meeting Dates: | 2004 Dec 4-7 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2004-11-16 |
| Start Page: | 7A |
| Language: | English |
| ACCESSION: | WOS:000225127500013 |
| PROVIDER: | wos |
| PUBMED: | 15562524 |
| DOI: | 10.1182/blood.V104.11.10.10 |
| Notes: | Meeting Abstract: 10 -- 46th Annual Meeting of the American-Society-of-Hematology -- DEC 04-07, 2004 -- San Diego, CA -- 1 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
